|Rajiv Kumar*, Gurkirat Kaur, Swarnjeet Singh, Rohit Bansal, Navdeep Singh and Ramanpreet Kaur Randhawa|
|Corresponding Author: Rajiv Kumar, Consultant Microbiologist & Head of laboratory Medicine, Delhi Heart Institute and Multispeciality Hospital , Bathinda (Punjab), India|
|Received: October 19, 2019; Accepted: November 25, 2019; Published: January 08, 2020;|
|Citation: Kumar R, Kaur G, Singh S, Bansal R, Singh N, et al. (2020) Pulmonary Nocardia Infection Diagnosed by Bronchopulmonary Lavage in Malwa Region of Punjab. Int J Radiography Imaging Radiat Ther, 2(1): 60-63.|
|Copyrights: ©2020 Kumar R, Kaur G, Singh S, Bansal R, Singh N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
Nocardiosis is a disease caused by a type of bacteria that is found in the environment, typically in standing water, decaying plants and soil. These bacterial species belong to the genus Nocardia and considered to be opportunistic pathogens. Nocardiosis is a common opportunistic infection found in Patients both immunocompromised and immunocompetent, cancer or on certain medications. Pulmonary Nocardiosis shows clinical symptoms similar to Pulmonary Tuberculosis. Bronchopulmonary lavage has also provided fresh dimension for the investigation of pulmonary nocardia and other disorders.
Keywords: Nocardia, Pulmonary Nocardiosis, Bronchopulmonary lavage
Nocardia is aerobic actinomycetes group of bacteria which are gram-positive bacilli showing branching filamentous forms, are non-spore forming and mildly acid-fast bacteria . These bacteria are saprophytic and are found in soil and water .
Pulmonary infection with Nocardia spp. show clinical symptoms similar to those suspected with pulmonary tuberculosis (fever, cough, chest pain, night sweats, weight loss and pneumonia) [3,4]. Infections with Nocardia spp. usually occur in individuals with weakened immune system and can include patients suffering from diabetes, malignancies, HIV/AIDS, lung disorders like pulmonary alveolar proteinosis (plugged lung air sacs), individuals with connective tissue disorders, chronic alcoholism, transplant patients and patients on corticosteroid therapy. It has been noted that more than 60% of human nocardiosis occurs in immunocompromised individuals and that males are more prone to infection than females (3:1) [4-7] and immunocompetent [8-11] individual was reported recently in the literature. Previous study has also elaborated on the types of radiological findings in pulmonary nocardiosis that include consolidation of the lungs, presence of nodules and masses, pleural effusion and extension of lung infection towards the chest wall resulting in abscess [12-15].
Bronchopulmonary lavage (BAL) has provided a fresh dimension for the investigation of pulmonary disorders. BAL fluid may be analysed for cells and chemical mediators in the diagnosis and also serially for the management of several granulomatous Disorders including sarcoidosis, extrinsic allergic alveolitis, chronic beryllium disease, talc granulomatosis, tuberculosis, Langerhans' histiocytosis-x and Crohn's disease . It may also provide information in fibrosing alveolitis, collagen vascular disease, occupational and drug-induced lung disease, acquired immune deficiency syndrome, bronchial asthma, neoplasia, transplantation, pulmonary alveolar proteinosis and eosinophilic lung disease. This study is planned to analyses the value of BAL in Nocardia infection.
MATERIALS AND METHODS
The medical records of patients with a diagnosis of nocardiosis maintained by Unique Hospital identification number at Delhi Heart Institute and Multispeciality Hospital, Bathinda (Punjab), India from 2018-2019 were retrospectively reviewed. Bronchopulmonary lavage (BAL collected by Bronchoscope) is used for this study which showed positive modified acid-fast stained filamentous bead-branching organisms (Figure 1)  or a positive culture or both. Epidemiologic data, clinical, chest X-ray, data were collected. The specimens from the patients were usually inoculated in routine non-selective media for Bacteria, fungi and mycobacteria.
Over the study period, there were 13 cases of nocardiosis at Delhi Heart Institute and Multispeciality Hospital, Bathinda (Punjab), India. Data of 13 cases were collected. The age, sex distribution (male/female 3:1) and underlying diseases (found in 80% of cases) are shown in Table 1. Immunosuppressive agents (either corticosteroids or methotrexate treatment) having connective tissue disease used in 61.5% of cases followed by chronic lung disease (15.3%) and diabetes mellitus (15.3%) and Grave’s disease was also found in one case.
The common clinical findings were fever, cough and hemoptysis (Table 2). Only 15.3% of patients had fever less than one week before presentation. Septic shock was documented at initial presentation in three cases.
Chest radiographs of all 13 cases were reviewed with a radiologist. The abnormal findings are summarized in Table 3. The common abnormalities were alveolar infiltrates (39.1), patchy opacities (36.9%), cavity lesion (21.7%) reticulo-nodular infiltration (17.4%) were found either alone or concurrently with infiltration.
Nocardiosis is a common opportunistic infection in immune compromised hosts that can cause serious or disseminated disease. More than 60% of all reported cases of nocardiosis are associated with pre-existing immune compromise ranging from alcoholism and diabetes to organ transplantation and AIDS. Persons requiring long-term corticosteroid or methotrexate treatment are also at risk with underlying diseases.
Pulmonary disease is the predominant clinical finding followed by connective tissue disease (61.5%), which is similar to other reports .
Whereas chest pain is (30.7%) cough, expectorate and headache has shown (23%) followed by dyspnea (15.3%). No difference between alveolar and reticulonodular or interstitial pattern of pulmonary infiltration was found. Although cavitation was common in pulmonary nocardiosis (21.7%) found in this study.
Nocardiosis is still a major problem in immune compromised hosts. Pulmonary infection was the predominant manifestation. Positive smears of Nocardia were seen in only 60% of cases, which may have resulted in missed or Delayed diagnosis in the remainder. Therefore, nocardiosis should be suspected in immune compromised and Methotrexate-treatment patients, whereas bronchopulmonary lavage has also provided a fresh dimension for the investigation of pulmonary disorders.
1. Gordon MA (1985) Manual of Clinical Microbiology. Washington, D.C: American Society for Microbiology. Aerobic Pathogenic Actinomycetaceae, Chapter 23: 249-262.
2. Conville PS, Witebsky FG (2007) Manual of Clinical Microbiology. 9th Edn. Washington, D.C: American Society for Microbiology. Nocardia, Rhodococcus, Gordonia, Actinomadura, Streptomyces and other aerobic actinomycetes, pp: 515-542.
3. Conville PS, Brown JM, Steigerwalt AG, Judy WL, Dorothy EB, et al. (2003) Nocardia veterana as a pathogen in north American patients. Clin Microbiol 41: 2560-2568.
4. Piau C, Kerjouan M, Le Mouel M, Patrat-Delon S, Henaux PL, et al. (2015) First case of disseminated infection with Nocardia cerradoensis in a human. Clin Microbiol 53: 1034-1037.
5. Ambrosioni J, Lew D, Garbino J (2010) Nocardiosis updated clinical review and experience at a tertiary center. Infection 38: 89-97.
6. Flateau C, Jurado V, Lemaître N, Loïez C, Wallet F, et al. ( 2013) First case of cerebral abscess due to a novel Nocardia species in an immunocompromised patient. Clin Microbiol 51: 696-700.
7. Al Akhrass F, Hachem R, Mohamed JA, Tarrand J, Kontoyiannis DP, et al. (2011) Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis 17: 1651-1658.
8. Wilson JW (2012) Nocardiosis: Updates and clinical overview. Mayo Clin Proc 87: 403-407.
9. Beaman BL, Beaman L (1994) Nocardia species: Host-parasite relationships. Clin Microbiol Rev 7: 213-264.
10. Mootsikapun P, Intarapoka B, Liawnoraset W (2005) Nocardiosis in Srinagarind Hospital, Thailand. Int J Infect Dis 3: 154-158.
11. Patil M, Shivaprasad C, Varghese J, Rajagopalan N (2012) A fatal case of pulmonary nocardiosis. BMJ Case Rep 2012: bcr0920114875.
12. Martínez R, Reyes S, Menéndez R (2008) Pulmonary nocardiosis: Risk factors, clinical features, diagnosis and prognosis. Curr Opin Pulm Med 14: 219-227.
13. Yagi K, Ishii M, Namkoong H, Asami T, Fujiwara H, et al. (2014) Pulmonary nocardiosis caused by Nocardia cyriacigeorgica in patients with Mycobacterium avium complex lung disease: Two case reports. BMC Infect Dis 14: 684.
14. Kanne JP, Yandow DR, Mohammed TL, Meyer CA (2011) CT findings of pulmonary nocardiosis. AJR Am J Roentgenol 197: 266-272.
15. Andalibi F, Mehdi FB, Parvin H, Masoumeh RN, Shadi H, et al. (2015) Isolation and identification of Nocardia spp. using phenotypic methods from soil samples of north Khorasan province. J Med Bacteriol 4: 8-14.
16. James DG, Rizzato G, Sharma OP (1992) Bronchopulmonary lavage (BAL). A window of the lungs. Sarcoidosis 1: 3-14.
17. (2015) Nocardiosis: DBMB.
18. George K, Michael SBJ (2018) Nocardiosis. Infectious Disease.
- Journal of Allergy Research(ISSN:2642-326X)
- Journal of Psychiatry and Psychology Research(ISSN:2640-6136)
- Journal of Pathology and Toxicology Research
- Advance Research on Alzheimers and Parkinsons Disease
- Journal of Nursing and Occupational Health
- Journal of Rheumatology Research(ISSN:2641-6999)
- Journal of Oral Health and Dentistry(ISSN:2638-499X)